Anti-Cancer Drugs provides current information on the clinical and experimental effects of toxic and non-toxic cancer agents and is specifically directed towards breakthroughs in cancer treatment. Among the topics included are cytotoxic chemotherapy, hormonal or biological response modifiers such as interleukins, immunotherapy, drug design, adverse effects of drugs and drug resistance. Within the journal, strong emphasis is placed on papers reporting treatments to alleviate the side-effects of chemotherapy.
2012 Impact factor 2.232*.
An individual subscription includes 10 print issues, full-text online access to all current and back issues, as well access to Anti-Cancer Drugs for the iPad! ®.
Visit the journal online at anti-cancerdrugs.com
*2012 Journal Citation Reports® (Thomson Reuters, 2013)
--Original clinical reports
--Fast publication time
--Provides new developments and breakthrough research
--2012 Impact Factor: 2.232*
--2012 Ranking: 115 of 196 Oncology, 127 of 260 Pharmacology & Pharmacy*
*2012 Journal Citation Reports
® (Thomson Reuters, 2013)
Mels Sluyser PhD
The Netherlands Cancer Institute, Amsterdam, The Netherlands